实用临床医药杂志2013，Vol.17Issue(14)：46-47,2.DOI:10.7619/jcmp.201314015
右美托咪定在行无创通气治疗的重症哮喘患者中的疗效评价
Research on application of dexmedetomidine in noninvasive ventilation in treating severe asthma
李学军 1张英飞1
作者信息
- 1. 河北省遵化市人民医院,河北遵化,064200
- 折叠
摘要
Abstract
Objective To explore The clinical efficacy of the application of dexmedetomidine in noninvasive ventilation in treating severe asthma.Methods The medical records of the 79 patients,who were admitted to Department of pneumology due to severe asthma were analyzed retrospectively.The patients were divided into three groups in terms of the difference of therapies:conventional treatment group (A group) which involved 26 cases,conventional and noninvasive ventilation treatment group (B group) 26 cases,conventional,noninvasive ventilation and dexmedetomidine treatment group (C group) 27 cases.We observed the three groups in terms of records of asthma remission rate,the average time of asthma remission,rate of invasive mechanical ventilation and aspiration rate.Results Asthma remission rate,the average time of asthma remission,rate of invasive mechanical ventilation of group C were lower than groups A and B (P ＜ 0.05).While aspiration rate of three groups was not statistically significant(P ＞0.05).Conclusion Noninvasive ventilation and dexmedetomidine treatment is an effective treatment in treating severe asthma,which can improve the asthma remission rate,reduce the average time of asthma remission and avoid the side-effects of mechanical ventilation.关键词
右美托咪定/无创正压通气/重症哮喘Key words
dexmedetomidine/ noninvasive ventilation/ severe asthma分类
医药卫生引用本文复制引用
李学军,张英飞..右美托咪定在行无创通气治疗的重症哮喘患者中的疗效评价[J].实用临床医药杂志,2013,17(14):46-47,2.
